Serotonergic function in cocaine addicts: Prolactin responses to sequential D,L-fenfluramine challenges

Biological Psychiatry

Volumn 45, Issue 10, 1999, Pages 1300-1306

  Buydens Branchey, Laure ^a,b   Branchey, Marc ^a,b   Hudson, Jeffrey ^b   Rothman, Michael ^b   Fergeson, Paul ^b   McKernin, Craig ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain serotonin; Cocaine addicts; Fenfluramine challenges; Prolactin

Indexed keywords

COCAINE; FENFLURAMINE; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; HORMONE RESPONSE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONIN RELEASE; SEROTONIN UPTAKE;

ADMINISTRATION, ORAL; ADULT; ALCOHOLISM; CHILD OF IMPAIRED PARENTS; COCAINE-RELATED DISORDERS; FATHERS; FENFLURAMINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PLACEBOS; PROLACTIN; SEROTONIN; SUBSTANCE-RELATED DISORDERS;

EID: 0033562953     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00268-6     Document Type: Article

References (37)

1. Andreasen N, Endicott J, Spitzer R, Winokur G (1977): The family history method using diagnostic criteria. Arch Gen Psychiatry 34:1229-1235.
2. Aronson SC, Black JE, McDougle CJ, et al (1995): Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology 119:179-185.
3. Babor TF, Hofmann M, DelBoca FK, et al (1992): Types of alcoholics. I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 4:599-608.
4. Ball SA, Carroll RM, Babor TF, Rounsaville BJ (1995): Subtypes of cocaine abusers: Support for a type A-type B distinction. J Consult Clin Psychol 63:115-124.
5. Balldin J, Berggren V, Engel J, Eriksson M (1994): Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol Clin Exp Res 18(4):822-825.
6. Barratt ES (1957): Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep 21:343-349.
7. Batki SL, Manfredi LB, Peyton J, Jacob P, Jones RT (1993): Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Pharmacol 13:243-250.
8. Batki SL, Washburn AM, Delucchi K, Jones RT (1996): A controlled trial of fluoxetine in crack-cocaine dependence. Drug Alcohol Depend 41:137-142.
9. 1A-mediated prolactin secretion in rats. Neurosci Lett 193:9-12.
10. Buss AH, Durkee A (1957): An inventory for assessing different kinds of hostility. J Consult Clin Psychol 21:343-349.
11. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C (1997): The m-CPP challenge test in cocaine addicts: Hormonal and psychological responses. Biol Psychiatry 41:1071-1086.
12. Cloninger CR (1987): Neurogenic adaptive mechanisms in alcoholism. Science 236:410-416.
13. Covi L, Hess JM, Kreiter NA, Haertzen CA (1995): Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 21:327-344.
14. Cunningham KA, Bradberry CW, Chang AS, Reith ME (1996): The role of serotonin in the actions of psychostimulants, molecular and pharmacological analyses. Behav Brain Res 73:93-102.
15. Cunningham KA, Lakoski JM (1990): The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsychopharmacology 3:41-50.
16. Dackis CA, Gold MS (1985): Concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477.
17. Dworkin SI, Conchita C, Smith JE (1995): Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res 682:116-126.
18. Egan MF, Wing L, Li R, Kirch DG, Wyatt RJ (1994): Effects of chronic cocaine treatment on rat brain: Long-term reduction in frontal cortical serotonin. Biol Psychiatry 36:637-640.
19. Farren CK, Ziedonis D, Clare AW, Dinan TG (1995): D-fenfluramine-induced prolactin responses in post-withdrawal alcoholics and controls. Alcohol Clin Exp Res 19(6):1578-1582.
20. First MB, Spitzer RL, Gibbon M, Williams JBW (1997a): Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
21. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LSB (1997b): Structured Clinical Interview for DSM IV Axis II Personality Disorders (SCID II). Washington, DC: American Psychiatric Press.
22. Gawin FH, Kleber HD (1986): Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113.
23. Grabowski J, Rhoades H, Elk R, et al (1995): Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials. J Clin Psychopharmacol 15:163-174.
24. Krebs HA, Cheng LK, Wright GH (1984): Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr B Biomed Sci Appl 310:412-417.
25. 1A agonist 8-OH-DPAT. Neuropharmacology 33:335-342.
26. Levy AD, Rittenhouse PA, Bonadonna AM, Alvarez Sanz MC, Bethea CL, Van de Kar LD (1993): Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin but not adrenocorticotropin secretion. Eur J Pharmacol 241:275-278.
27. Levy AD, Rittenhouse PA, Li Q, et al (1992): Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats. Brain Res 580:6-11.
28. McBride PA, Tierney H, DeMeo M, Chen JS, Mann J (1990): Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27:1143-1155.
29. McDougle CJ, Black JE, Malison RT, et al (1994): Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51:713-719.
30. McDougle CJ, Price LH, Palumbo JM, Kosten TR, Heninger GR, Kleber HD (1992): Dopaminergic responsivity during cocaine abstinence: A pilot study. Psychiatry Res 43:77-85.
31. Naranjo CA, Brenner KE (1994): Serotonin-altering medications and desire, consumption, and effects of alcohol: Treatment implications. In: Jansson B, Jörnvall H, Rydberg U, et al, editors. Towards a Molecular Basis of Alcohol Use and Abuse. Basel, Switzerland: Birkhaüser, pp 209-219.
32. Parsons LH, Koob GF, Weiss F (1995): Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exper Ther 274:1182-1191.
33. Pitts DK, Marwah J (1987): Cocaine modulation of central monoaminergic neurotransmission. Pharmacol Biochem Behav 26:453-461.
34. Pollack MH, Rosenbaum JF (1991): Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 52:31-33.
35. Satel SL, Price LH, Palumbo JM, et al (1991): Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 148:1712-1716.
36. Virkkunen M, Linnoila M (1990): Serotonin in early onset male alcoholics with violent behavior. Ann Med 22:327-331.
37. Weddington WW, Brown BS, Haertzen CA, et al (1990): Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 47:861-868.